vs
Side-by-side financial comparison of Gen Digital (GEN) and SELECT MEDICAL HOLDINGS CORP (SEM). Click either name above to swap in a different company.
SELECT MEDICAL HOLDINGS CORP is the larger business by last-quarter revenue ($1.4B vs $1.2B, roughly 1.1× Gen Digital). Gen Digital runs the higher net margin — 15.5% vs 1.4%, a 14.0% gap on every dollar of revenue. On growth, Gen Digital posted the faster year-over-year revenue change (28.5% vs 6.4%). Over the past eight quarters, Gen Digital's revenue compounded faster (13.2% CAGR vs 2.8%).
Gen Digital Inc. is a multinational software company co-headquartered in both Tempe, Arizona (USA) and Prague, Czech Republic (EU). The company provides cybersecurity software, financial technology, and services. Gen is a Fortune 500 company and a member of the S&P 500 stock-market index. It is listed at both NASDAQ and Prague Stock Exchange. Its portfolio includes Norton, Avast, LifeLock, Avira, AVG, ReputationDefender, MoneyLion and CCleaner.
Select Medical is a healthcare company based in Pennsylvania. It owns long-term acute care and inpatient rehabilitation hospitals, as well as occupational health and physical therapy clinics. Select Medical is a subsidiary of Select Medical Holdings, which is listed on the New York Stock Exchange.
GEN vs SEM — Head-to-Head
Income Statement — Q3 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.2B | $1.4B |
| Net Profit | $192.0M | $20.2M |
| Gross Margin | 78.4% | — |
| Operating Margin | 34.9% | 4.6% |
| Net Margin | 15.5% | 1.4% |
| Revenue YoY | 28.5% | 6.4% |
| Net Profit YoY | 6.1% | 225.7% |
| EPS (diluted) | $0.31 | $0.17 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $1.2B | — | ||
| Q4 25 | $1.2B | $1.4B | ||
| Q3 25 | $1.3B | $1.4B | ||
| Q2 25 | — | $1.3B | ||
| Q1 25 | $1.0B | $1.4B | ||
| Q4 24 | $986.0M | $1.3B | ||
| Q3 24 | $974.0M | $1.3B | ||
| Q2 24 | $965.0M | $1.3B |
| Q1 26 | $192.0M | — | ||
| Q4 25 | $134.0M | $20.2M | ||
| Q3 25 | $135.0M | $28.8M | ||
| Q2 25 | — | $40.6M | ||
| Q1 25 | $142.0M | $56.7M | ||
| Q4 24 | $159.0M | $-16.1M | ||
| Q3 24 | $161.0M | $55.6M | ||
| Q2 24 | $181.0M | $77.6M |
| Q1 26 | 78.4% | — | ||
| Q4 25 | 78.2% | — | ||
| Q3 25 | 78.8% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 80.3% | — | ||
| Q4 24 | 80.4% | — | ||
| Q3 24 | 80.1% | — | ||
| Q2 24 | 80.3% | — |
| Q1 26 | 34.9% | — | ||
| Q4 25 | 35.9% | 4.6% | ||
| Q3 25 | 35.5% | 5.4% | ||
| Q2 25 | — | 6.5% | ||
| Q1 25 | 41.3% | 8.3% | ||
| Q4 24 | 37.9% | 1.6% | ||
| Q3 24 | 41.3% | 4.3% | ||
| Q2 24 | 43.2% | 5.8% |
| Q1 26 | 15.5% | — | ||
| Q4 25 | 11.0% | 1.4% | ||
| Q3 25 | 10.7% | 2.1% | ||
| Q2 25 | — | 3.0% | ||
| Q1 25 | 14.1% | 4.2% | ||
| Q4 24 | 16.1% | -1.2% | ||
| Q3 24 | 16.5% | 4.4% | ||
| Q2 24 | 18.8% | 6.1% |
| Q1 26 | $0.31 | — | ||
| Q4 25 | $0.21 | $0.17 | ||
| Q3 25 | $0.22 | $0.23 | ||
| Q2 25 | — | $0.32 | ||
| Q1 25 | $0.22 | $0.44 | ||
| Q4 24 | $0.26 | $-0.12 | ||
| Q3 24 | $0.26 | $0.43 | ||
| Q2 24 | $0.29 | $0.60 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $26.5M |
| Total DebtLower is stronger | $8.4B | $1.8B |
| Stockholders' EquityBook value | $2.3B | $1.7B |
| Total Assets | $15.8B | $5.9B |
| Debt / EquityLower = less leverage | 3.61× | 1.06× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | — | $26.5M | ||
| Q3 25 | — | $60.1M | ||
| Q2 25 | — | $52.3M | ||
| Q1 25 | $1.0B | $53.2M | ||
| Q4 24 | $883.0M | $59.7M | ||
| Q3 24 | $737.0M | $191.5M | ||
| Q2 24 | $644.0M | $111.2M |
| Q1 26 | $8.4B | — | ||
| Q4 25 | $8.7B | $1.8B | ||
| Q3 25 | $8.9B | $1.7B | ||
| Q2 25 | — | $1.8B | ||
| Q1 25 | $8.3B | $1.8B | ||
| Q4 24 | $8.5B | $1.7B | ||
| Q3 24 | $8.5B | $3.1B | ||
| Q2 24 | $8.5B | $3.6B |
| Q1 26 | $2.3B | — | ||
| Q4 25 | $2.5B | $1.7B | ||
| Q3 25 | $2.4B | $1.7B | ||
| Q2 25 | — | $1.7B | ||
| Q1 25 | $2.3B | $1.7B | ||
| Q4 24 | $2.2B | $1.7B | ||
| Q3 24 | $2.1B | $1.9B | ||
| Q2 24 | $2.0B | $1.4B |
| Q1 26 | $15.8B | — | ||
| Q4 25 | $16.1B | $5.9B | ||
| Q3 25 | $16.4B | $5.7B | ||
| Q2 25 | — | $5.7B | ||
| Q1 25 | $15.5B | $5.7B | ||
| Q4 24 | $15.4B | $5.6B | ||
| Q3 24 | $15.5B | $8.0B | ||
| Q2 24 | $15.4B | $7.9B |
| Q1 26 | 3.61× | — | ||
| Q4 25 | 3.54× | 1.06× | ||
| Q3 25 | 3.75× | 1.03× | ||
| Q2 25 | — | 1.10× | ||
| Q1 25 | 3.64× | 1.03× | ||
| Q4 24 | 3.94× | 1.01× | ||
| Q3 24 | 4.06× | 1.62× | ||
| Q2 24 | 4.33× | 2.54× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $64.3M |
| Free Cash FlowOCF − Capex | — | $5.2M |
| FCF MarginFCF / Revenue | — | 0.4% |
| Capex IntensityCapex / Revenue | — | 4.2% |
| Cash ConversionOCF / Net Profit | — | 3.19× |
| TTM Free Cash FlowTrailing 4 quarters | — | $117.2M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $541.0M | $64.3M | ||
| Q3 25 | $409.0M | $175.3M | ||
| Q2 25 | — | $110.3M | ||
| Q1 25 | $473.0M | $-3.5M | ||
| Q4 24 | $326.0M | $125.4M | ||
| Q3 24 | $158.0M | $181.0M | ||
| Q2 24 | $264.0M | $278.2M |
| Q1 26 | — | — | ||
| Q4 25 | $535.0M | $5.2M | ||
| Q3 25 | $405.0M | $122.2M | ||
| Q2 25 | — | $45.6M | ||
| Q1 25 | $470.0M | $-55.8M | ||
| Q4 24 | $318.0M | $62.0M | ||
| Q3 24 | $156.0M | $130.3M | ||
| Q2 24 | $262.0M | $222.6M |
| Q1 26 | — | — | ||
| Q4 25 | 43.9% | 0.4% | ||
| Q3 25 | 32.2% | 9.0% | ||
| Q2 25 | — | 3.4% | ||
| Q1 25 | 46.5% | -4.1% | ||
| Q4 24 | 32.3% | 4.7% | ||
| Q3 24 | 16.0% | 10.2% | ||
| Q2 24 | 27.2% | 17.4% |
| Q1 26 | — | — | ||
| Q4 25 | 0.5% | 4.2% | ||
| Q3 25 | 0.3% | 3.9% | ||
| Q2 25 | — | 4.8% | ||
| Q1 25 | 0.3% | 3.9% | ||
| Q4 24 | 0.8% | 4.8% | ||
| Q3 24 | 0.2% | 4.0% | ||
| Q2 24 | 0.2% | 4.3% |
| Q1 26 | — | — | ||
| Q4 25 | 4.04× | 3.19× | ||
| Q3 25 | 3.03× | 6.09× | ||
| Q2 25 | — | 2.72× | ||
| Q1 25 | 3.33× | -0.06× | ||
| Q4 24 | 2.05× | — | ||
| Q3 24 | 0.98× | 3.25× | ||
| Q2 24 | 1.46× | 3.59× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
GEN
| Cyber Safety Platform | $819.0M | 66% |
| Trust Based Solutions | $421.0M | 34% |
| Net Interest Income On Notes Receivable | $4.0M | 0% |
SEM
| Critical Illness Recovery Hospitals | $629.7M | 45% |
| Health Care Patient Service Non Medicare | $428.6M | 31% |
| Rehabilitation Hospitals | $339.2M | 24% |
